- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Bafna Pharmaceuticals Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting
11-02-2026 | 05:50 pm
11-02-2026 | 05:50 pm
Bafna Pharmaceuticals' board approved financial results for the quarter and nine-months ended Dec 31, 2025. Revenue from operations for the quarter stood at ₹38.29 Cr, with a profit of ₹1.86 Cr.
No comments yet. Be the first to comment!